Atlas Trials

A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia

Clinical trial NCT00222794 · COMPLETED

Trial details

NCT number
NCT00222794
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2003-11-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.